This compound is a pharmaceutical intermediate featuring a thiazole ring and a cyano-substituted phenyl ether structure. It is primarily used as a building block in the synthesis of active pharmaceutical ingredients.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 160844-75-7
Febuxostat
active pharmaceutical ingredient
2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline
pharmaceutical intermediate
1-[7-Amino-5-(2-bromopropyl)-2,3-dihydro-1H-indol-1-yl]ethanone
Pharmaceutical intermediate for synthesis
2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl Methanesulfonate
pharmaceutical intermediate
3-Acetyl-2-(aminosulfonyl)-5-chlorothiophene
Pharmaceutical intermediate for sulfonamide synthesis
Ethyl 2-[3-formyl-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylate
pharmaceutical intermediate
Ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methyl-5-thiazolecarboxylate
pharmaceutical intermediate
Ethyl 2-(4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate
Pharmaceutical intermediate for thiazole derivatives
ethyl 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylate
OGAZOYHQFBSRMC-UHFFFAOYSA-N
CCOC(=O)C1=C(N=C(S1)C2=CC(=C(C=C2)OCC(C)C)C#N)C